๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The development of vitamin D3analogues for the treatment of osteoporosis

โœ Scribed by Y. Nishii; K. Sato; T. Kobayashi

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
459 KB
Volume
3
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Vitamin D analogues in the treatment of
Vitamin D analogues in the treatment of psoriasis
โœ Knud Kragballe ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 641 KB

Psoriasis is a chronic hyperproliferative skin disease in which inflammatory and immunologic processes may play important pathophysiologic roles. Recently the skin has been identified as a target tissue for vitamin D. Because 1,25-dihydroxy vitamin D3 inhibits epidermal proliferation and promotes ep

Rationale for active vitamin D and analo
Rationale for active vitamin D and analogs in the treatment of osteoporosis
โœ Yasuho Nishii ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB

## Abstract In 1981, Chugai Pharmaceutical succeeded in marketing alfacalcidol, a prodrug of calcitriol, as a therapeutic agent for renal osteodystrophy. In 1983, Chugai succeeded in extending the application of alfacalcidol to the treatment of osteoporosis as well. Clinicians in Japan have accepte